July 9, 2026
CCPA Submits Comments to FDA on Peptide Compounding
CCPA Submits Comments to FDA on Peptide Compounding The Chronic Care Policy Alliance (CCPA) submitted comments to the FDA’s Pharmacy…
Read MoreJuly 9, 2026
CCPA Submits Comments to FDA on Peptide Compounding The Chronic Care Policy Alliance (CCPA) submitted comments to the FDA’s Pharmacy…
Read MoreApril 2, 2026
For people living with the chronic disease of obesity, GLP-1 medications have been life-changing. Research shows that sustained use reduces…
Read More